Yield10 Bioscience: Q3 Earnings Insights

Yield10 Bioscience (NASDAQ:YTEN) reported its Q3 earnings results on Tuesday, November 14, 2023 at 04:01 PM. Here’s what…

Yield10 Bioscience (NASDAQ:YTEN) reported its Q3 earnings results on Tuesday, November 14, 2023 at 04:01 PM.

Here’s what investors need to know about the announcement.

Earnings

Yield10 Bioscience missed estimated earnings by 5.13%, reporting an EPS of $-0.41 versus an estimate of $-0.39.

Revenue was down $111 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.1 which was followed by a 0.0% increase in the share price the next day.

Here’s a look at Yield10 Bioscience’s past performance:

Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022
EPS Estimate -0.54 -0.63 -0.60 -0.65
EPS Actual -0.64 -0.76 -0.67 -0.71
Revenue Estimate 30K 70K 120K 130K
Revenue Actual 0 60K 87K 111K

To track all earnings releases for Yield10 Bioscience visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

This Undervalued Cannabis Stock Has Another Year Of Growth: Reports Record 2023 Revenue And Adjusted EBITDA

Decibel Cannabis Company reported on Monday its audited financial results for the three and twelve month periods ending Dec. 31, 2023. The Calgary, Alberta-based company said it saw a record net revenue of CA$116 million ($84.8 million) in 2023, an increase of 46% over 2022. "The Company's fourth quarter financial results delivered another year of growth across all metrics and I look forward to working with the team to continue to build on this success" Benjamin Sze, Decibel's new CEO, said. Sze was recently appointed to serve as Decibel's CEO, succeeding Paul Wilson. He rejoined the company after previously serving as CEO before resigning in late 2020 to focus on his family.

DB